Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Joensuu, Heikki ; Eriksson, Mikael LU orcid ; Sundby Hall, Kirsten ; Reichardt, Annette ; Hartmann, Jörg T ; Pink, Daniel ; Ramadori, Giuliano ; Hohenberger, Peter ; Al-Batran, Salah-Eddin and Schlemmer, Marcus , et al. (2016) In Journal of Clinical Oncology 34(3). p.244-250
Abstract
Three years of adjuvant imatinib therapy are recommended for patients with GI stromal tumor (GIST) with high-risk features, according to survival findings in the Scandinavian Sarcoma Group XVIII/AIO (Arbeitsgemeinschaft Internistische Onkologie) trial. To investigate whether the survival benefits have persisted, we performed the second planned analysis of the trial.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Oncology
volume
34
issue
3
pages
244 - 250
publisher
American Society of Clinical Oncology
external identifiers
  • pmid:26527782
  • scopus:84955616130
  • wos:000374331100012
  • pmid:26527782
ISSN
1527-7755
DOI
10.1200/JCO.2015.62.9170
language
English
LU publication?
yes
id
2997816b-44eb-4b71-9d3f-a21e14b68365 (old id 8243484)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26527782?dopt=Abstract
date added to LUP
2016-04-04 08:46:21
date last changed
2022-04-23 17:53:55
@article{2997816b-44eb-4b71-9d3f-a21e14b68365,
  abstract     = {{Three years of adjuvant imatinib therapy are recommended for patients with GI stromal tumor (GIST) with high-risk features, according to survival findings in the Scandinavian Sarcoma Group XVIII/AIO (Arbeitsgemeinschaft Internistische Onkologie) trial. To investigate whether the survival benefits have persisted, we performed the second planned analysis of the trial.}},
  author       = {{Joensuu, Heikki and Eriksson, Mikael and Sundby Hall, Kirsten and Reichardt, Annette and Hartmann, Jörg T and Pink, Daniel and Ramadori, Giuliano and Hohenberger, Peter and Al-Batran, Salah-Eddin and Schlemmer, Marcus and Bauer, Sebastian and Wardelmann, Eva and Nilsson, Bengt and Sihto, Harri and Bono, Petri and Kallio, Raija and Junnila, Jouni and Alvegård, Thor and Reichardt, Peter}},
  issn         = {{1527-7755}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{244--250}},
  publisher    = {{American Society of Clinical Oncology}},
  series       = {{Journal of Clinical Oncology}},
  title        = {{Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.}},
  url          = {{http://dx.doi.org/10.1200/JCO.2015.62.9170}},
  doi          = {{10.1200/JCO.2015.62.9170}},
  volume       = {{34}},
  year         = {{2016}},
}